RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 91 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $201,167 | +36.3% | 8,775 | -1.9% | 0.00% | 0.0% |
Q2 2023 | $147,569 | -9.2% | 8,949 | -1.7% | 0.00% | 0.0% |
Q1 2023 | $162,487 | -18.9% | 9,108 | +32.4% | 0.00% | 0.0% |
Q4 2022 | $200,316 | +31.8% | 6,879 | +11.2% | 0.00% | 0.0% |
Q3 2022 | $152,000 | +850.0% | 6,188 | +65.4% | 0.00% | – |
Q2 2022 | $16,000 | -62.8% | 3,742 | 0.0% | 0.00% | – |
Q1 2022 | $43,000 | -20.4% | 3,742 | -30.7% | 0.00% | – |
Q4 2021 | $54,000 | -26.0% | 5,398 | -3.1% | 0.00% | – |
Q3 2021 | $73,000 | -33.0% | 5,571 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $109,000 | -6.8% | 5,571 | +1.3% | 0.00% | 0.0% |
Q1 2021 | $117,000 | +5.4% | 5,502 | +47.0% | 0.00% | 0.0% |
Q4 2020 | $111,000 | +37.0% | 3,742 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $81,000 | -2.4% | 3,742 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $83,000 | +151.5% | 3,742 | +71.2% | 0.00% | – |
Q1 2020 | $33,000 | -34.0% | 2,186 | 0.0% | 0.00% | – |
Q4 2019 | $50,000 | – | 2,186 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |